ArticleThe Journal of pharmacology and experimental therapeutics2024
Minor Cannabinoids as an Emerging Frontier for Pain Relief.
Michael J Ippolito, Eric R Gross, Khaled S Abd-Elrahman
Abstract read
In one paragraphArticle in The Journal of pharmacology and experimental therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
3 authors.
Michael J IppolitoDepartment of Neural Sciences, Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania (M.J.I.); Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (E.R.G.); Department of Anesthesiology, Pharmacology and Therapeutics and Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, British Columbia (K.S.A.-E.); Department of Medical Sciences, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates (K.S.A.-E.); and Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (K.S.A.-E.).ORCID https://orcid.org/0000-0001-5881-4910 Eric R GrossDepartment of Neural Sciences, Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania (M.J.I.); Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (E.R.G.); Department of Anesthesiology, Pharmacology and Therapeutics and Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, British Columbia (K.S.A.-E.); Department of Medical Sciences, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates (K.S.A.-E.); and Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (K.S.A.-E.) ergross@stanford.edu.
Khaled S Abd-ElrahmanDepartment of Neural Sciences, Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania (M.J.I.); Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (E.R.G.); Department of Anesthesiology, Pharmacology and Therapeutics and Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, British Columbia (K.S.A.-E.); Department of Medical Sciences, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates (K.S.A.-E.); and Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (K.S.A.-E.).ORCID https://orcid.org/0000-0001-9724-1975 Funding
TRAINING PROGRAM: DRUGS OF ABUSE RELATED NEUROPEPTIDEST32DA007237 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLEN M UNTERWALD · 1988 to 2026
$10.6MPrecision Targeting of Aldehyde Pathways for Patients Requiring AnesthesiaR35GM119522 · NIGMS · STANFORD UNIVERSITY · PI Eric Richard Gross · 2016 to 2026
$5.1MNIDA NIH HHS T32 DA007237NIGMS NIH HHS R35 GM119522
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID39424317
PMCPMC11776475
What OpenQuestion holds
Textmetadata
Read underepoch 390